跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEVA-ATAZANAVIR - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TEVA-ATAZANAVIR
Authorized
STANDARD
TEVA-ATAZANAVIR
teva canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
9304b7cbed27d032
Company
teva canada limited
Type
Standard
Approval Details
Approval Id
9304b7cbed27d032
Drug Approval Canada Name
TEVA-ATAZANAVIR
Product Name
TEVA-ATAZANAVIR
Status
Marketed
Status Date
2017-04-18
Original Market Date
2017-04-18
Din
02443791
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:18.08.08
Atc Original
J05AE08 ATAZANAVIR
Atc Name
j 05 ae 08
Aig Number
0149741002
Company Name
teva canada limited
Company Address
30 Novopharm Court, Toronto, Ontario, Canada, M1B 2K9
Active Ingredients
ATAZANAVIR (ATAZANAVIR SULFATE)
150 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
9304b7cbed27d032
Type
Standard
Back to Health Canada Approvals